Prostate Cancer Prevention in the Developing World - What are we Waiting for?

Publisher： Bentham Science Publishers

E-ISSN： 1875-6913|10|1|70-86

ISSN： 1875-6921

Source： Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol.10, Iss.1, 2012-03, pp. : 70-86

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prostate Cancer Prevention by Silibinin

By  

Current Cancer Drug Targets, Vol. 4, Iss. 1, 2004-02 ,pp. : 1-11

Bentham Science Publishers

Access to resources Recommend Favorite

Prevention of bone metastases in prostate cancer

By  

Inpharma, Vol. 1, Iss. 1392, 2003-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Agents in development for prostate cancer prevention

By Nelson William G  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 12, 2004-12 ,pp. : 1541-1554

Informa Healthcare

Access to resources Recommend Favorite

Outcomes of 200 Patients with Localized Prostate Cancer Enrolled in a Watchful Waiting Protocol

By Grimaldi J.P.   Fleshner Neil   DeBoer Gerrit   Choo Richard   Klotz Laurence  

UroOncology, Vol. 2, Iss. 2, 2002-01 ,pp. : 93-94

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Flavonoids and Cancer Prevention: What Is the Evidence in Humans?

By Neuhouser Marian  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 42, Iss. 1, 2004-01 ,pp. : 36-45

Informa Healthcare

Access to resources Recommend Favorite